David Fajgenbaum

David Fajgenbaum

professorMale0.0Global Dominance: 0.00%

David Fajgenbaum is a physician and researcher at the University of Pennsylvania, known for his groundbreaking work in drug repurposing to treat rare diseases, particularly Castleman disease, which he himself battled. His innovative approach and establishment of the nonprofit Every Cure aim to utilize AI to identify overlooked treatments, significantly impacting patient care.

Power0
Reach0
Collect

Not in the pool (under ¢1).

Recent news mentions

David Fajgenbaum is mentioned in a story about finding treatments for diseases.

This is the moment that changed Sanjay Gupta’s career
CNN·United StatesUnited States· 2025-09-08
7.0

David Fajgenbaum is featured for his work in finding a treatment for his disease.

Video: Ukrainian refugee stabbed on Charlotte light rail train
CNN·United StatesUnited States· 2025-09-08
9.0

David Fajgenbaum suggested an unconventional treatment for Joseph Coates's rare disorder.

La IA descubre cura oculta de enfermedad en medicamentos olvidados
La Prensa – high-circulation Honduran daily·HondurasHonduras· 2025-04-07
9.0

David Fajgenbaum suggested an unconventional treatment combination that helped Joseph Coates.

como a IA está encontrando novas soluções para salvar vidas
O Globo·BrazilBrazil· 2025-04-06
9.0

Dr. David Fajgenbaum suggested an unconventional therapy to help Joseph Coates using AI.

«La tua malattia è incurabile»: l'intelligenza artificiale crea un mix di farmaci che gli salva la vita
Corriere della Sera·ItalyItaly· 2025-03-22
9.0

David Fajgenbaum suggested an unconventional treatment for Joseph Coates' rare blood disorder.

Doctors told him he was going to die. Then AI saved his life
The New Zealand Herald – country’s largest newspaper, est. 1863·New ZealandNew Zealand· 2025-03-22
9.0

Fajgenbaum went on to become a professor at the University of Pennsylvania and began seeking out other drugs with unknown uses.

Doctors told Joseph he was going to die. Then AI saved his life
The Sydney Morning Herald·AustraliaAustralia· 2025-03-21
9.0